SPOP Antibody (2N8L8)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-15784
Recombinant Monoclonal Antibody
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 2N8L8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthetic peptide corresponding to a sequence within amino acids 250-350 of human SPOP (O43791). VFKEMMCFIYTGKAPNLDKMADDLLAAADKYALERLKVMCEDALCSNLSVENAAEILILADLHSADQLKTQAVDFINYHASDVLETSGWKSMVVSHPHLVA
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for SPOP Antibody (2N8L8)
Western Blot: SPOP Antibody (2N8L8) [NBP3-15784]
Western Blot: SPOP Antibody (2N8L8) [NBP3-15784] - Western blot analysis of extracts of PC-3 cells, using SPOP Rabbit mAb (NBP3-15784) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 180s.Applications for SPOP Antibody (2N8L8)
Application
Recommended Usage
Western Blot
1:500 - 1:1000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 0.05% BSA, 50% glycerol, pH7.3
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: SPOP
Alternate Names
HIB homolog 1, Roadkill homolog 1, speckle-type POZ protein, TEF2
Gene Symbol
SPOP
Additional SPOP Products
Product Documents for SPOP Antibody (2N8L8)
Product Specific Notices for SPOP Antibody (2N8L8)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...